# A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing Cholangitis

> clinical trial · VERIFIED · 2026-07-02

Status: RECRUITING · Sponsor: Ipsen · Condition: Primary Sclerosing Cholangitis

- Company: Ipsen
- Sector: pharma
- Primary source: https://clinicaltrials.gov/study/NCT07387549

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.